258 Participants Needed

Vivacit-E Liner for Hip Osteoarthritis

Recruiting at 4 trial locations
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Zimmer Biomet
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

How is the Vivacit-E Liner treatment different from other hip osteoarthritis treatments?

The Vivacit-E Liner is unique because it uses a vitamin E-infused, highly cross-linked polyethylene material, which is designed to reduce wear and oxidative degradation, potentially leading to longer-lasting hip replacements compared to traditional materials.12345

What is the purpose of this trial?

This trial is testing a special hip replacement part made from durable plastic in patients needing hip surgery. The goal is to see if it reduces wear and tear, improves pain, and enhances movement.

Research Team

RB

Ryan Boylan, MBA

Principal Investigator

Zimmer Biomet

Eligibility Criteria

This trial is for adults aged 18-60 with hip conditions like osteoarthritis or avascular necrosis who need a new hip joint (total hip arthroplasty). They must be skeletally mature, have not had previous hip replacements on the affected side, and be able to follow the study's procedures and visits.

Inclusion Criteria

I am willing and able to follow the required treatment after surgery.
My bones have stopped growing.
I need a hip replacement due to conditions like osteoarthritis or hip dysplasia.
See 9 more

Exclusion Criteria

The patient is known to be pregnant
I have been diagnosed with Rheumatoid Arthritis.
I am currently dealing with an infection.
See 12 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Vivacit-E HXPE Liner with the Continuum acetabular shell implant

Surgery and immediate postoperative period

Initial Follow-up

Initial evaluation of the implanted Vivacit-E HXPE Liners for bedding in, and linear and volumetric wear

6 weeks
1 visit (in-person)

Long-term Follow-up

Participants are monitored for safety, device survivorship, and functional outcomes using various scores and radiographic analysis

10 years
Annual visits (in-person)

Treatment Details

Interventions

  • Vivacit-E Liner
Trial Overview The Vivacit-E Liner used in total hip replacements is being studied. Researchers want to see how well it performs by looking at wear over time, patient outcomes through surveys and x-rays, and any reported problems.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Vivacit-E LinerExperimental Treatment1 Intervention
All subjects enrolled receive the study implant.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Zimmer Biomet

Lead Sponsor

Trials
383
Recruited
67,800+
Dr. Nitin Goyal profile image

Dr. Nitin Goyal

Zimmer Biomet

Chief Medical Officer since 2021

MD from Harvard Medical School

Ivan Tornos profile image

Ivan Tornos

Zimmer Biomet

Chief Executive Officer since 2023

MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business

References

Performance of thin Vivacit-E hip liners: no relevant wear during ex vivo testing at high acetabular inclination angle. [2023]
Safety of vitamin E-infused highwall liners for routine use in primary total hip arthroplasty: single centre, short-term follow-up of 1221 cases. [2022]
Minimum 7-Year Follow-Up of Vitamin E-Diffused and Highly Cross-Linked Polyethylene Liners in Total Hip Arthroplasty: Findings From a Prospective, International, Multicenter Study of 977 Patients. [2023]
Early unexpected failure of a vitamin E-infused highly cross-linked polyethylene liner: A case report. [2023]
Early Fracture of a Vitamin-E-Infused, Highly Cross-Linked Polyethylene Liner After Total Hip Arthroplasty: A Case Report. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security